Archive: 12/04/2017

1st drug for tardive dyskinesia approved

(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.

page 3 from 8